NCT06602778

Brief Summary

In this study, we investigated the effects of physical activity level and sleep quality level on total antioxidant level (TAS), total oxidant level (TOS), Malondialdehyde (MDA) and Superoxide Dismutase (SOD) which are markers of oxidative stress, irisin, fibronectin type III-protein 5 (FNDC5).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 17, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

September 20, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2025

Completed
Last Updated

March 19, 2025

Status Verified

September 1, 2024

Enrollment Period

1 month

First QC Date

September 17, 2024

Last Update Submit

March 15, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • biomarkers derived from blood sera

    blood glucose, total cholesterol, triglycerides, LDL and HDL analyzes

    10 Minutes

  • ELISA method of oxidative stress markers

    All reagents of the ELISA kits of the oxidative stress markers TAS, TOS, MDA and SOD will be brought to room temperature. Standards will be prepared according to the protocol and added to a 96-well plate with the samples. Buffer solution will be added to each well and incubated for 90 min at room temperature. After each step, necessary washes will be performed and finally chromogenic agents will be added and read spectrophotometrically. Although the timing and additions may vary according to the parameter, in general the procedure is as indicated. Each sample will be run 2 times for both TAS and TOS

    10 minutes

  • Analysis of exercise-related markers by ELISA method

    10 minutes

  • International Physical Activity Questionnaire

    5 minutes

  • Pittsburgh Sleep Quality Index

    5 minutes

Study Arms (4)

T2DM-BMI0

Other: Biomarkers / bloodOther: Questionnaire

T2DM-BMI1

Other: Biomarkers / bloodOther: Questionnaire

T2DM-BMI2

Other: Biomarkers / bloodOther: Questionnaire

T2DM-BMI3

Other: Biomarkers / bloodOther: Questionnaire

Interventions

Analysis of routine biochemical parameters

T2DM-BMI0T2DM-BMI1T2DM-BMI2T2DM-BMI3

Physical activity level will be assessed using the International Physical Activity Questionnaire Short Form (IPQI) and sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). The data to be obtained from blood will be obtained by selecting blood samples that will be sent to biological waste.

T2DM-BMI0T2DM-BMI1T2DM-BMI2T2DM-BMI3

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients applying to the endocrinology department at the medical faculty hospital

You may qualify if:

  • Being between 30-65 years old
  • Volunteering to participate in the study
  • Being literate
  • Being diagnosed with Type 2 Diabetes

You may not qualify if:

  • Having a physical or mental illness that prevents communication
  • malignant disease,
  • infectious disease,
  • chronic obstructive pulmonary disease,
  • liver disease,
  • patients with kidney disease and joint or muscle disease will not be included

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Selcuk University

Konya, Selcuklu, 42130, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

BiomarkersBlood Specimen CollectionSurveys and Questionnaires

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Biological FactorsSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative TechniquesData CollectionEpidemiologic MethodsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assist.Prof.Dr.

Study Record Dates

First Submitted

September 17, 2024

First Posted

September 19, 2024

Study Start

September 20, 2024

Primary Completion

October 20, 2024

Study Completion

February 25, 2025

Last Updated

March 19, 2025

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations